What are Vericel's total assets?

Vericel (VCEL) holds $485.6M in total assets, up 14.4% year over year.

How much debt does Vericel have?

Vericel carries $95.0M in total debt against $356.2M of shareholders' equity, a debt-to-equity ratio of 0.27.

How much cash does Vericel have?

Vericel holds $109.3M in cash and equivalents.

Can Vericel cover its short-term obligations?

Its current ratio is 5.18 — current assets exceed current liabilities.

Where does Vericel's balance sheet data come from?

Every line is extracted from Vericel's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Vericel VCEL Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$109.3M+37.1%	$100.09M+17.7%	$100.4M+42.7%	$80.53M+6.2%	$79.71M+12.7%
Short-term investments	$36.05M-8.5%	$37.41M-10.3%	$34.98M-27.2%	$36.35M-30.4%	$39.41M-17.4%
Restricted cash	$0-100%	$0-100%	$0-100%	$0-100%	$6.22M-20.4%
Accounts receivable, net	$72.38M+36.8%	$84.63M+37.9%	$60.43M+24.6%	$64.29M+33.9%	$52.9M+5.9%
Inventories	$18.35M+7.3%	$17.56M+1.1%	$18.16M+15.2%	$16.83M+13.1%	$17.11M+26.2%
Raw materials	$13.75M+16.2%	$12.95M+1.0%	$12.7M+7.2%	$11.24M-2.2%	$11.83M+9.0%
Work in process	$1.51M-5.0%	$1.58M+0.8%	$1.47M-20.8%	$2.05M+14.9%	$1.59M-9.1%
Finished goods	$3.09M-16.1%	$3.02M+1.6%	$3.99M+94.2%	$3.54M+120%	$3.69M+286%
Prepaid expenses and other current assets	$7.99M-6.2%	$7.74M+6.3%	$8.01M+1.6%	$6.58M+2.2%	$8.52M+9.6%
Total current assets	$244.06M+23.5%	$247.44M+16.3%	$221.97M+16.5%	$204.58M+3.6%	$197.64M+4.2%
Property and equipment, net	$107.11M-1.1%	$108.4M+5.1%	$109.38M+23.7%	$109.85M+50.3%	$108.29M+92.0%
Accumulated depreciation	$34.66M+49.0%	$31.55M+17.3%	$28.72M+12.3%	$25.93M+5.4%	$23.26M-0.7%
Total property and equipment, gross	$141.77M+7.8%	$139.95M+7.6%	$138.1M+21.1%	$135.78M+39.0%	$131.55M+64.8%
Operating lease right-of-use assets	$63.41M-7.7%	$64.77M-7.6%	$66.09M-7.6%	$67.4M-7.7%	$68.72M-6.7%
Intangible assets, net	$5.47M-10.3%	$5.63M-10.0%	$5.78M-9.8%	$5.94M-9.5%	$6.09M-9.3%
Other non-current assets	$288K-42.5%	$341K-38.7%	$395K-35.2%	$447K-32.7%	$501K-30.1%
Long-term investments	——	——	——	——	——
Available-for-sale securities	$65.28M+50.6%	$61.4M+53.9%	$49.66M+51.0%	$47.4M+81.5%	$43.34M+47.3%
Allowance for credit losses	$0—	$0—	$0—	$0—	$0—
Total assets	$485.63M+14.4%	$487.97M+12.8%	$453.27M+16.1%	$435.61M+15.6%	$424.59M+19.0%
Accounts payable	$19.01M+13.5%	$15.83M-33.6%	$15.34M-26.6%	$12.86M-49.0%	$16.75M-13.8%
Accrued expenses	$4.25M+9.1%	$3.01M+2,494%	$3.6M+16.7%	$4.58M+7.5%	$3.9M+14.8%
Current portion of long-term debt	$116K—	$116K—	$116K—	——	——
Operating lease liabilities, current	$14.06M+26.0%	$13.97M+50.9%	$13.85M+126%	$13.75M+137%	$11.16M+85.7%
Finance Lease Liability, Current	——	——	——	——	——
Claims and insurance accruals	$3.73M+22.0%	$4.4M+39.3%	$3.77M+13.1%	$2.86M+3.9%	$3.05M-9.8%
Total current liabilities	$47.16M+19.5%	$49.15M-2.3%	$45.58M+10.2%	$41.13M-6.2%	$39.45M+8.2%
Operating lease liabilities, non-current	$80.36M-8.5%	$82.28M-8.2%	$84.16M-7.9%	$86.01M-4.2%	$87.8M+1.9%
Finance lease liabilities	$501K—	$522K—	$543K—	——	——
Other non-current liabilities	$1.88M+1.7%	$1.9M+116%	$1.67M+588%	$1.66M+736%	$1.85M+1,100%
Total liabilities	$129.4M+0.2%	$133.33M-5.3%	$131.42M-1.1%	$128.8M-3.8%	$129.1M+5.2%
Common stock	75M0.0%	75M-89.0%	75M0.0%	75M0.0%	75M0.0%
Retained earnings	-$382.6M+5.3%	-$376.3M+4.2%	-$399.54M+3.2%	-$404.61M+1.7%	-$404.06M+0.7%
Accumulated other comprehensive income (loss)	-$168K-224%	$275K+6,775%	$258K-28.1%	$183K+167%	$136K+156%
Total stockholders' equity	$356.23M+20.6%	$354.64M+21.5%	$321.86M+25.0%	$306.81M+26.3%	$295.49M+26.3%
Total liabilities and stockholders' equity	$485.63M+14.4%	$487.97M+12.8%	$453.27M+16.1%	$435.61M+15.6%	$424.59M+19.0%
Available-for-Sale Debt Securities - Amortized Cost	$101.5M+22.9%	$98.53M+20.8%	$84.38M+4.7%	$83.57M+6.3%	$82.62M+6.8%
Allowance for Doubtful Accounts	$13K+333%	$13K+30.0%	$19K+58.3%	$1K-90.0%	$3K-96.6%
Allowance for Doubtful Accounts Receivable (Current)	$13K+333%	$13K+30.0%	$19K+58.3%	$1K-90.0%	$3K-96.6%
Cash, Cash Equivalents, and Marketable Securities	$101.33M+22.4%	$98.8M+21.1%	$84.64M+4.6%	$83.75M+6.9%	$82.75M+7.3%
Other current assets	$7.99M-6.2%	$7.74M+6.3%	$8.01M+1.6%	$6.58M+2.2%	$8.52M+9.6%
Deferred Tax Assets and Other Non-Current Assets	$288K-42.5%	$341K-38.7%	$395K-35.2%	$447K-32.7%	$501K-30.1%
Investments - Amortized Cost Basis	$101.5M+22.9%	$98.53M+20.8%	$84.38M+4.7%	$83.57M+6.3%	$82.62M+6.8%
Net Investment in Lease	$63.41M-7.7%	$64.77M-7.6%	$66.09M-7.6%	$67.4M-7.7%	$68.72M-6.7%
Long-term marketable securities	$65.28M+50.6%	$61.4M+53.9%	$49.66M+51.0%	$47.4M+81.5%	$43.34M+47.3%
Intangible assets — net	$5.47M-10.3%	$5.63M-10.0%	$5.78M-9.8%	$5.94M-9.5%	$6.09M-9.3%
Investments	——	——	——	——	——
Operating lease right-of-use assets	$63.41M-7.7%	$64.77M-7.6%	$66.09M-7.6%	$67.4M-7.7%	$68.72M-6.7%
Other non-current assets	$288K-42.5%	$341K-38.7%	$395K-35.2%	$447K-32.7%	$501K-30.1%
Property, plant and equipment, net	$107.11M-1.1%	$108.4M+5.1%	$109.38M+23.7%	$109.85M+50.3%	$108.29M+92.0%
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	$36.05M-8.5%	$37.41M-10.3%	$34.98M-27.2%	$36.35M-30.4%	$39.41M-17.4%
Operating Lease Right-of-Use Assets in Other Assets	$63.41M-7.7%	$64.77M-7.6%	$66.09M-7.6%	$67.4M-7.7%	$68.72M-6.7%
Software and Technology Licenses, Net	$288K-42.5%	$341K-38.7%	$395K-35.2%	$447K-32.7%	$501K-30.1%
Accrued Manufacturing Costs	$4.25M+9.1%	$3.01M-8.0%	$3.6M+16.7%	$4.58M+7.5%	$3.9M+14.8%
Other Commercial Liabilities	$13.97M+22.3%	$19.24M+12.7%	$16.29M+13.5%	$14.4M+12.0%	$11.42M+3.6%
Accrued Liabilities, Current	$13.97M+22.3%	$19.24M+12.7%	$16.29M+13.5%	$14.4M+12.0%	$11.42M+3.6%
Compensation and benefits	$4.25M+9.1%	$3.01M-8.0%	$3.6M+16.7%	$4.58M+7.5%	$3.9M+14.8%
Other accrued liabilities	$116K—	$116K—	$116K—	——	——
Total debt	$95.04M-4.6%	$97.01M-2.7%	$98.67M+1.2%	$100.44M+5.1%	$99.65M+8.1%
Common Stock Shares Issued	51M+1.5%	50.6M+2.0%	50.6M+2.6%	50.4M+3.2%	50.3M+3.6%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$739M+5.7%	$730.66M+6.7%	$721.14M+7.7%	$711.24M+8.6%	$699.41M+9.1%
Unrealized Gains on Investments	$97K-43.9%	$315K+158%	$293K-21.9%	$218K+4,260%	$173K—
Unrealized Losses on Investments (Before Tax)	$265K+616%	$40K-66.1%	$35K+119%	$35K-87.4%	$37K-84.7%
Cumulative Cost Basis	$101.5M+22.9%	$98.53M+20.8%	$84.38M+4.7%	$83.57M+6.3%	$82.62M+6.8%
Accrued bonuses	$4.67M+14.5%	$11.25M+9.1%	$8.28M+9.3%	$6.42M+13.7%	$4.08M+3.7%
Other accrued expenses	$1.32M+237%	$573K+76.9%	$627K+84.4%	$543K+177%	$391K+24.1%
Allowance for doubtful accounts	$13K+333%	$13K+30.0%	$19K+58.3%	$1K-90.0%	$3K-96.6%
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	$265K+616%	$40K-66.1%	$35K+119%	$35K-87.4%	$37K-84.7%
Gross Unrealized Gains	$97K-43.9%	$315K+158%	$293K-21.9%	$218K+4,260%	$173K—
Total	$101.5M+22.9%	$98.53M+20.8%	$84.38M+4.7%	$83.57M+6.3%	$82.62M+6.8%
Available for sale investments	$101.33M+22.4%	$98.8M+21.1%	$84.64M+4.6%	$83.75M+6.9%	$82.75M+7.3%
Common stock, shares authorized (in shares)	$75M0.0%	$75M0.0%	$75M0.0%	$75M0.0%	$75M0.0%
Common stock, shares issued (in shares)	$51.01M+1.5%	$50.62M+2.0%	$50.55M+2.6%	$50.44M+3.2%	$50.25M+3.6%
Common Stock, Shares, Outstanding	$51.01M+1.5%	$50.62M+2.0%	$50.55M+2.6%	$50.44M+3.2%	$50.25M+3.6%
Debt Securities, Available-for-Sale, Allowance for Credit Loss	$0—	$0—	$0—	$0—	$0—
Current maturities of long-term debt	$116K—	$116K—	$116K—	——	——
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	$686K—	$686K—	$686K—	——	——
Raw materials	$13.75M+16.2%	$12.95M+1.0%	$12.7M+7.2%	$11.24M-2.2%	$11.83M+9.0%
Lease Liability Noncurrent	$95.04M-4.6%	$96.89M-2.7%	$98.67M+1.2%	$100.44M+5.1%	$99.65M+8.1%
Number of specialty pharmacies	——	——	——	——	——
Number of commercial-stage products	——	——	——	——	——
Right Of Use Asset	$64.1M—	$65.46M—	$66.77M—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Vericel.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Vericel's total assets?: Vericel (VCEL) holds $485.6M in total assets, up 14.4% year over year.
How much debt does Vericel have?: Vericel carries $95.0M in total debt against $356.2M of shareholders' equity, a debt-to-equity ratio of 0.27.
How much cash does Vericel have?: Vericel holds $109.3M in cash and equivalents.
Can Vericel cover its short-term obligations?: Its current ratio is 5.18 — current assets exceed current liabilities.
Where does Vericel's balance sheet data come from?: Every line is extracted from Vericel's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.